Moreover, such a strategy would not be very efficient in patients with T1D where endogenous insulin levels are very low and the daily insulin injections would disturb the normal insulin concentration gradient that might drive the insulin-specific CAR-Tregs into the pancreas. This evidence concerns the gene INS and type 1 diabetes mellitus.